April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses the diverse therapeutic properties of Hibiscus rosa sinensis, including anti-inflammatory and anti-cancer effects, and notes that while most extracts showed no toxicity, some altered biological markers, necessitating further research to explore its medicinal potential through clinical trials.
October 2022 in “International Journal For Multidisciplinary Research” This review summarizes Hibiscus rosa Sinensis's phytochemistry, pharmacology, and medicinal uses, noting various beneficial effects and the need for further research on its phytochemicals and clinical applications.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review outlines the therapeutic uses and phytochemical composition of Hibiscus rosa sinensis, highlighting its potential anti-inflammatory, anti-cancer, and other benefits, but it also calls for more research due to observed changes in hematological and biochemical markers in toxicity tests.
1 citations
,
May 2025 in “International Journal of Advanced Biochemistry Research” This review discusses the phytochemical, pharmacological, and medicinal properties of Hibiscus rosa sinensis Linn. and reports no new clinical findings.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review found that Hibiscus rosa sinensis extracts exhibit diverse medicinal properties, such as anti-inflammatory and antioxidant effects, with minimal toxicity at high doses, though some altered blood markers, indicating a need for further research into their mechanisms and clinical applications.